Tarsus Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Tarsus Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-13 | $-0.61 | $-0.94 | 35.1 % |
Jun 2024 | 2024-08-08 | $-0.88 | $-0.93 | 5.38 % |
Mar 2024 | 2024-05-08 | $-1.01 | $-1.20 | 15.8 % |
Dec 2023 | 2024-02-27 | $-1.31 | $-1.36 | 3.68 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-13 | $48.12M | $43.44M | 10.8 % |
Jun 2024 | 2024-08-08 | $40.81M | $31.71M | 28.7 % |
Mar 2024 | 2024-05-08 | $27.61M | $17.83M | 54.9 % |
Dec 2023 | 2024-02-27 | $13.08M | $5.66M | 131.0 % |
Tarsus Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3.
Tarsus Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3 and the Actual EPS was $-0.61, which beat the estimate of $-0.94.
Tarsus Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.